Jabra Enhance Plus enters new OTC hearing aid category, empowering millions of Americans with mild to moderate hearing loss to take the first step on their hearing health journey

Jabra Enhance Plus is now available in stores and online at Best Buy and at Jabra.com, expanding current availability within ReSound and Beltone hearing care clinics

LOWELL, Mass. , Oct. 17, 2022 /PRNewswire/ -- GN, the global leader in intelligent audio solutions, today announces that the Jabra Enhance Plus hearing enhancement earbuds are now available over the counter (OTC). This follows the US Food & Drug Administration's (FDA) new regulation establishing an OTC hearing aid category, which is now in effect. As an OTC product, the Jabra Enhance Plus will help millions of Americans with unaddressed hearing loss take the first step on their hearing health journey.

As an OTC product, Jabra Enhance Plus will help millions of Americans with unaddressed hearing loss.

Today, millions of people in the US with hearing loss benefit from the advice and care of a hearing care professional. However, there are still 50 million more who find themselves noticing some degree of hearing loss, perhaps occasionally and typically in noisy situations, who have not yet sought or found a solution that helps them with their hearing challenges. Jabra Enhance Plus is engineered specifically for this audience.

Jabra Enhance Plus hearing enhancement earbuds deliver a 3-in-1 experience of hearing enhancement, music and calls in a miniaturized true wireless form factor design, around half the size of Jabra's smallest true wireless earbuds. It includes the calls and music functionality that users expect from true wireless earbuds and provides hearing help for users in a miniaturized, discreet and comfortable design. Their extremely small size helps them visually blend in during conversations. The earbuds can be individualized via a user's smartphone through the Jabra Enhance app. The seamless set-up experience can be completed in minutes and users will have access to convenient and simple controls to adjust volume and focus mode for any environment.

"The new OTC hearing aid regulation represents a significant opportunity to improve hearing health for millions experiencing mild to moderate hearing loss," said Calum MacDougall , SVP at Jabra. "We look forward to bringing the Jabra Enhance Plus to more consumers under the new OTC category and helping to improve people's quality of life through the power of sound."

Jabra Enhance Plus has been selling through GN's network of ReSound and Beltone hearing care partners and has succeeded in opening hearing health care to a new audience. On average, Jabra Enhance Plus users are 18 years younger than users of GN's prescription hearing aid range*. With Jabra Enhance Plus under the new OTC hearing aid category, this innovative hearing health solution will be more widely accessible to consumers in new channels.

As an OTC product, Jabra Enhance Plus can be bought as easily as a pair of headphones in Best Buy or online, but for those looking for more support, the nationwide network of Certified Jabra Enhance Centers (supplied by GN's select Hearing Care Professional partners) is available to offer consultation and advice with the purchase. Find a Certified Jabra Enhance Center here.

Jabra Enhance Plus** is now available in stores and online at Best Buy and at Jabra.com, expanding current availability within ReSound and Beltone hearing care clinics. Learn more about the Jabra Enhance Plus at www.jabra.com/enhance-plus.

Read the initial press releases from August 18, 2021  and February 08, 2022 .

* Internal GN data from US market ** Only compatible with iPhone devices

About Jabra Jabra is a world leading brand in audio, video, and collaboration solutions – engineered to empower consumers and businesses. Proudly part of the GN Group, which includes world-leading expertise in both audio and hearing solutions, we've committed over 150 years to making life sound better, opening a world of sound without limits. Our cutting-edge innovations in hearing care are engineered for you – whoever you are, whatever you do – and founded in the belief that great sound should be as individual as your personality. Jabra is part of the GN Group – pioneering great sound from world-leading hearing aids and office headsets, to cutting-edge sports headphones. www.jabra.com

About GN Group The GN Group enables people to Hear More, Do More and Be More through its intelligent hearing, audio and video collaboration solutions. Inspired by people and driven by our innovation leadership, we leverage technological synergies between our hearing and audio divisions to deliver unique and increasingly individualized user experiences in our products and solutions. 150 years ago, GN was founded with a truly innovative and global mindset. Today, we honor that legacy with world-leading expertise in the human ear, sound and video processing, wireless technology, miniaturization and collaborations with leading technology partners. GN's solutions are marketed by the brands ReSound, Beltone, Interton, Jabra, BlueParrott and FalCom in 100 countries. Founded in 1869, operates in 100+ countries, employs 7,000 people and is listed on Nasdaq Copenhagen (GN.CO). Visit our homepage GN.com, get to know our innovation and leadership, and connect with us on LinkedIn and Facebook.

© 2022 GN Group A/S. All rights reserved. Jabra® is a registered trademark of GN Audio A/S. All other trademarks included herein are the property of their respective owners (design and specifications are subject to change without notice)

Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced positive topline efficacy and safety data from the Phase 3 RAPID clinical trial of etripamil, the Company's investigational calcium channel blocker, in patients with paroxysmal supraventricular tachycardia (PSVT).

These growth stocks have plunged alongside the broader market, creating a rare buying opportunity for investors.

Major telecom and tech companies such as Apple are starting to roll out features—like text messaging, SOS alerts and location tracking—that work with current or next-generation cellphones instead of relying on satellite-messaging tools. The first version of this technology is a big step forward for cellphones—but it likely won’t give us the “always connected” life people dream about. Then there are immediate issues: Devices have to have a clear view of the satellite to work, which could make the connectivity less effective in hilly areas or places with other tall structures.

Indian telecom service provider Reliance Jio has chosen Nokia as a major supplier, the Finnish telecom equipment maker said on Monday, as India's biggest mobile carrier gears up to expand next-generation wireless services across the country. Nokia will supply Reliance Jio, which has more than 420 million customers, with 5G radio access network (RAN) equipment in a multi-year deal, the company said in a statement. "Nokia will supply equipment from its AirScale portfolio, including base stations, high-capacity 5G Massive MIMO antennas, and Remote Radio Heads to support different spectrum bands, and self-organizing network software," it said.

Ultomiris was just approved in the European Union to treat patients with generalized myasthenia gravis.

Meta Platforms stock continues to underperform tech peers as the social media company spends its money generating demand for a future in the metaverse.

Shares of Milestone Pharmaceuticals Inc. gained 25.4% in premarket trading on Monday after the company said its experimental treatment for paroxysmal supraventricular tachycardia met the primary endpoint in a Phase 3 study. Paroxysmal supraventricular tachycardia is a type of arrhythmia. The treatment, etripamil, is a nasal spray. Milestone said it plans to submit a new drug application for etripamil to the Food and Drug Administration in mid-2023. The company's stock is up 29.6% this year, whil

Elon Musk has a penchant for the letter "X." He calls his son with the singer Grimes, whose actual name is a collection of letters and symbols, "X." He named the company he created to buy Twitter "X Holdings." His rocket company is, naturally, SpaceX. Now he also apparently intends to morph Twitter into an "everything app" he calls X.

Photo Illustration by Erin O'Flynn/The Daily Beast/GettyA new subvariant of the novel-coronavirus called XBB dramatically announced itself earlier this week, in Singapore. New COVID-19 cases more than doubled in a day, from 4,700 on Monday to 11,700 on Tuesday—and XBB is almost certainly why. The same subvariant just appeared in Hong Kong, too.A highly mutated descendant of the Omicron variant of the SARS-CoV-2 virus that drove a record wave of infections starting around a year ago, XBB is in ma

Medical stocks don't generally have high dividends, but Abbvie (NYSE: ABBV), Pfizer (NYSE: PFE), and Gilead Sciences (NASDAQ: GILD) all have dividends with yields of 3.5% or more, and these pharmaceuticals stocks serve as a great hedge against inflation because their business models are largely resistant to recessions. A high-yielding dividend without sound fundamentals can easily become a dividend trap, but all three of these companies have pipelines with great potential and a strong history of increasing revenue -- and none appear to be overpriced yet. AbbVie is a new Dividend King.

After announcing it nearly a year ago, Mercedes-Benz is finally rolling out Apple Music's Spatial Audio in select electric and luxury vehicles.

Nokia Canada and federal, provincial and municipal partners today announced plans to transform Nokia's Ottawa, ON, facility into a world-leading, sustainable research and development (R&D) hub. The tech center will significantly expand Nokia Canada's capacity in next-generation information and communications technology (ICT) and cyber security innovation. This transformation is expected to create more than 340 new, high-value jobs and help Nokia attract highly-skilled, global talent to Canada's

So far relatively few users are sticking around in Meta’s Horizon Worlds, much less building worlds as the company had hoped.

Cold and flu season is officially upon us. As the weather changes and our bodies will try to adapt to the new temperatures, our immune systems might begin to weaken. Whether you're feeling a little run down or so ill that you can't muster the strength to get out of bed, getting sick is never an enjoyable experience. So, when searching for solutions to help stave off illness or remedies that can facilitate healing when under the weather, adding more immune-boosting foods to your diet is one appro

Microsoft CEO Satya Nadella says the cloud can help companies become more efficient as they look for ways to save in the downturn.

Ryan Reynolds isn't just a world-famous actor, he's also the part owner of Mint Mobile, the mobile virtual network operator (MVNO) that touts a $15 a month cell phone plan using the T-Mobile 5G...

Walmart Inc. (WMT) is the latest retailer to begin selling hearing aids online and in its stores. The retail giant said it will begin selling two brands of hearings aids on Monday: Lexie powered by Bose, a brand that costs $849 to $999, and HearX, which costs $199 to $299. Both brands were developed by HearX Group, a privately held startup based in Pretoria.

The things to remember about dementia are that it is absolutely horrible for you and everyone around you; it’s a high probability; and when it comes to fighting it or avoiding it you are pretty much on your own. Alzheimer’s disease and related dementias are currently killing 6.5 million people in the United States and devastating the lives of many times that when you count the patients’ friends and family. The National Institutes of Health reckons this number is likely to double in the next four decades.

Some people are turning to Apple's AirTags to track loved ones with dementia. Public health officials warn it may not be the best choice, not just due to its tracking ability.

In this article, we shall discuss the 10 best weight loss stocks to buy now. To skip our detailed analysis of the obesity epidemic and its effects on the weight loss and fitness industry in 2022, go directly and see 5 Best Weight Loss Stocks To Buy Now. The 21st century has seen obesity emerge […]